Posizioni attive di Hema Keshava
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2021 | - |
| ABIVAX | Corporate Officer/Principal | 01/07/2023 | - |
Storia della carriera di Hema Keshava
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
| Francia | 2 |
Posizioni
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABIVAX | Health Technology |
| Aziende private | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Hema Keshava
- Esperienza
